CN107629014A - The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 - Google Patents
The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 Download PDFInfo
- Publication number
- CN107629014A CN107629014A CN201711009139.2A CN201711009139A CN107629014A CN 107629014 A CN107629014 A CN 107629014A CN 201711009139 A CN201711009139 A CN 201711009139A CN 107629014 A CN107629014 A CN 107629014A
- Authority
- CN
- China
- Prior art keywords
- synthetic method
- compound
- methyl
- alcohol
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种5‑甲基‑4H‑1,2,4‑三唑‑3‑乙酸I的合成方法,包括以下步骤:1)丙二酸二乙基酯和水合肼在醇溶剂中、室温下反应得到化合物1,2)化合物1与甲基乙亚胺酸酯盐酸盐2在适当溶剂中、在有机碱存在下以及回流温度下反应得到化合物3,3)化合物3在碱存在下,在醇溶剂中水解酯键,并加入适当酸进行酸化反应后得到化合物I,见以下反应路线:本发明的合成方法具有以下优点:合成路线的原料易得,价格便宜,各步骤的合成工艺条件温和,易于工业化生产。A kind of synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I, comprises the following steps: 1) diethyl malonate and hydrazine hydrate react in alcohol solvent, at room temperature Compound 1 is obtained, 2) compound 1 is reacted with methyl acetimidate hydrochloride 2 in a suitable solvent, in the presence of an organic base and at reflux temperature to obtain compound 3, 3) compound 3 is reacted in the presence of a base in alcohol The ester bond is hydrolyzed in a solvent, and compound I is obtained after adding an appropriate acid for acidification reaction, see the following reaction scheme: The synthesis method of the invention has the following advantages: the raw materials of the synthesis route are easy to obtain, the price is cheap, the synthesis process conditions of each step are mild, and the industrial production is easy.
Description
技术领域technical field
本发明涉及医药化工合成领域,具体涉及医药中间体5-甲基-4H-1,2,4-三唑-3-乙酸的合成方法。The invention relates to the field of pharmaceutical chemical synthesis, in particular to a synthesis method of a pharmaceutical intermediate 5-methyl-4H-1,2,4-triazole-3-acetic acid.
背景技术Background technique
三氮唑类杂环是一类重要的芳杂环,由于其易形成氢键,配位键等,并发挥多种非共价键相互作用,能够改善药物分子的水溶性等化学物理性质;被广泛地应用于药物合成、功能材料及分子生物学等方面。三氮唑结构中的1,2,4-三氮唑表现出各种各样的生物活性,例如伊曲康唑、曲康唑、泊沙康唑、阿巴康唑、氟康唑、艾氟康唑、伏立康唑等就是一类包含1,2,4-三氮唑的药物。Triazole heterocycles are an important class of aromatic heterocycles. Because they are easy to form hydrogen bonds, coordinate bonds, etc., and play a variety of non-covalent interactions, they can improve the chemical and physical properties of drug molecules such as water solubility; It is widely used in drug synthesis, functional materials and molecular biology. The 1,2,4-triazoles in the triazole structure exhibit various biological activities, such as itraconazole, traconazole, posaconazole, abaconazole, fluconazole, Fluconazole, voriconazole, etc. are a class of drugs containing 1,2,4-triazoles.
5-甲基-4H-1,2,4-三唑-3-乙酸,CAS.No.为720706-28-5,其结构式如式I所示;是一类重要的医药化工中间体,被广泛应用于药物及化工合成领域。例如文献报道了包含5-甲基-4H-1,2,4-三唑-3-乙酰基片段的新分子结构,是一类磷酸二酯酶受体,显示出广泛的抗肿瘤活性。5-Methyl-4H-1,2,4-triazole-3-acetic acid, CAS.No. is 720706-28-5, its structural formula is shown in formula I; it is an important class of pharmaceutical and chemical intermediates, and is Widely used in the field of pharmaceutical and chemical synthesis. For example, the literature reported a new molecular structure containing 5-methyl-4H-1,2,4-triazole-3-acetyl fragment, which is a kind of phosphodiesterase receptor, showing a wide range of antitumor activities.
Khomenko等在“Synthesis and study of novel 1,2,4-triazolylacetic acidderivatives”(Chem Heterocycl Comp,2016,52(6):402-408.)一文中,报道了将甲酰肼A与乙酸丙二酸酯单亚胺酯B在乙醇中回流反应得到相应5-甲基-1,2,4-三唑-3-乙酸酯3;再通过酯水解得到5-甲基-4H-1,2,4-三唑-3-乙酸I;见如下合成路线一。In the article "Synthesis and study of novel 1,2,4-triazolylacetic acidderivatives" (Chem Heterocycl Comp, 2016,52(6):402-408.), Khomenko et al. reported the combination of formic hydrazide A and acetic acid malonate Ester monoimide ester B was refluxed in ethanol to obtain the corresponding 5-methyl-1,2,4-triazole-3-acetate 3; and then hydrolyzed to obtain 5-methyl-4H-1,2, 4-triazole-3-acetic acid I; see the following synthetic route 1.
上述合成路线一中[9],乙酸丙二酸酯单亚胺酯B不易制备,限制了该方法的进一步应用。本发明旨在开发出一种简单便捷、适合工业化生产的5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法。In the above synthetic route 1 [9], malonate monoimide B is not easy to prepare, which limits the further application of this method. The present invention aims to develop a simple and convenient synthesis method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I suitable for industrial production.
发明内容Contents of the invention
本发明提供了一种5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法,包括以下步骤:1)丙二酸二乙基酯和水合肼在醇溶剂中、室温下反应得到丙二酸乙酯酰肼1(化合物1),2)化合物1与甲基乙亚胺酸酯盐酸盐2在适当溶剂中、在有机碱存在下以及回流温度下反应得到5-甲基-4H-1,2,4-三唑-3-乙酸酯3(化合物3),3)化合物3在碱存在下,在醇溶剂中水解酯键,并加入适当酸进行酸化反应后得到5-甲基-4H-1,2,4-三唑-3-乙酸酯I,见以下反应路线二:The invention provides a kind of synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I, comprises the following steps: 1) diethyl malonate and hydrazine hydrate in alcohol solvent , react at room temperature to obtain ethyl malonate hydrazide 1 (compound 1), 2) react compound 1 with methyl acetimidate hydrochloride 2 in a suitable solvent, in the presence of an organic base and at reflux temperature to obtain 5-Methyl-4H-1,2,4-triazole-3-acetate 3 (Compound 3), 3) Compound 3 hydrolyzes the ester bond in an alcohol solvent in the presence of a base, and acidifies by adding an appropriate acid After the reaction, 5-methyl-4H-1,2,4-triazole-3-acetate I was obtained, as shown in the following reaction scheme 2:
本发明的5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法,其中,甲基乙亚胺酸酯盐酸盐2通过在冰水浴中,搅拌下将HCl气体通入乙腈、甲醇和己烷的混合溶液中;在搅拌过程中反应得到。The synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I of the present invention, wherein, methyl acetimidate hydrochloride 2 is mixed HCl under stirring in ice-water bath The gas is passed into a mixed solution of acetonitrile, methanol and hexane; the reaction is obtained during stirring.
一种优选的实施方式,本发明的5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法,其中,步骤1)中所述醇溶剂选自甲醇、乙醇或丙醇,优选乙醇。A preferred embodiment, the synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I of the present invention, wherein, the alcohol solvent described in step 1) is selected from methanol, ethanol or Propanol, preferably ethanol.
一种优选的实施方式,本发明的5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法,其中,步骤2)中所述醇溶剂选自乙醇、正丙醇或异丙醇,优选异丙醇;所述有机碱选自二异丙基乙基胺、DBU或吡啶,优选二异丙基乙基胺。A preferred embodiment, the synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I of the present invention, wherein, the alcohol solvent described in step 2) is selected from ethanol, n-propyl Alcohol or isopropanol, preferably isopropanol; The organic base is selected from diisopropylethylamine, DBU or pyridine, preferably diisopropylethylamine.
一种优选的实施方式,本发明的5-甲基-4H-1,2,4-三唑-3-乙酸I的合成方法,其中,步骤3)中所述醇溶剂选自甲醇、乙醇、正丙醇或异丙醇,优选甲醇或乙醇;所述碱选自氢氧化钠、氢氧化钾;所述适当酸选自盐酸、硫酸;优选盐酸气体。A preferred embodiment, the synthetic method of 5-methyl-4H-1,2,4-triazole-3-acetic acid I of the present invention, wherein, the alcohol solvent described in step 3) is selected from methanol, ethanol, n-propanol or isopropanol, preferably methanol or ethanol; the base is selected from sodium hydroxide, potassium hydroxide; the appropriate acid is selected from hydrochloric acid, sulfuric acid; preferably hydrochloric acid gas.
本文开发了一条新的丙二酸二乙基酯为起始原料,与水合肼反应得到丙二酸乙酯酰肼1,再与甲基乙亚胺酸酯盐酸盐2在Hoenig碱存在进行缩合反应得到5-甲基-4H-1,2,4-三唑-3-乙酸酯3,最后将化合物3的酯键水解后得到5-甲基-4H-1,2,4-三唑-3-乙酸I,终产物收率高。该路线具有原料易得,价格便宜,各步骤的合成工艺条件温和,易于工业化生产。This paper developed a new diethyl malonate as the starting material, reacted with hydrazine hydrate to obtain ethyl malonate hydrazide 1, and then reacted with methyl ethyl imidate hydrochloride 2 in the presence of Hoenig base. The condensation reaction gives 5-methyl-4H-1,2,4-triazole-3-acetate 3, and finally the ester bond of compound 3 is hydrolyzed to give 5-methyl-4H-1,2,4-tri Azole-3-acetic acid I, the final product yield is high. The route has the advantages of readily available raw materials, low price, mild synthesis process conditions in each step, and easy industrial production.
具体实施方式detailed description
以下将通过具体实施例进一步阐述本发明,但并不用于限制本发明的保护范围。在不脱离本发明构思的前提下,本领域技术人员可在权利要求范围内对制备方法和使用仪器作出改进,这些改进也应视为本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。The following will further illustrate the present invention through specific examples, but it is not intended to limit the protection scope of the present invention. Without departing from the concept of the present invention, those skilled in the art can make improvements to the preparation method and equipment used within the scope of the claims, and these improvements should also be regarded as the protection scope of the present invention. Therefore, the protection scope of the patent for the present invention should be based on the appended claims.
下述实施例中,除非另有说明,所述的试验方法通常按照常规条件或制造厂商建议的条件实施;所示的原料、试剂均可通过市售购买的方式获得。In the following examples, unless otherwise specified, the test methods are generally implemented under conventional conditions or conditions suggested by the manufacturer; the raw materials and reagents shown can all be obtained through commercially available means.
实施例1.丙二酸乙酯酰肼1的制备Embodiment 1. The preparation of ethyl malonate hydrazide 1
丙二酸二乙酯(10g,62.5mmol)溶解于50ml乙醇中,然后添加85%水合肼(1.44g,1.44mol)。反应混合物在室温下搅拌过夜。停止反应,过滤,滤液减压蒸除溶剂。所得残留物用乙酸乙酯/石油醚的混合溶剂进行重结晶,得到化合物1(2.10g,64%),为白色固体。1HNMR(400MHz,DMSO-d6)δ4.12(q,J=7.1Hz,2H),3.16(s,2H),1.22(t,J=7.1Hz,3H);LC-MS147(M+H)+。Diethyl malonate (10 g, 62.5 mmol) was dissolved in 50 ml of ethanol, then 85% hydrazine hydrate (1.44 g, 1.44 mol) was added. The reaction mixture was stirred overnight at room temperature. Stop the reaction, filter, and evaporate the filtrate to remove the solvent under reduced pressure. The obtained residue was recrystallized from a mixed solvent of ethyl acetate/petroleum ether to obtain compound 1 (2.10 g, 64%) as a white solid. 1HNMR (400MHz, DMSO-d6) δ4.12(q, J=7.1Hz, 2H), 3.16(s, 2H), 1.22(t, J=7.1Hz, 3H); LC-MS147(M+H)+ .
实施例2.甲基乙亚胺酸酯盐酸盐2的制备Embodiment 2. The preparation of methyl acetimidate hydrochloride 2
在冰水浴中,搅拌下将HCl气体通入乙腈(30g,0.720mol)、甲醇(35ml,0.87mol)和己烷(150ml)的混合溶液中;在搅拌过程中,逐渐有白色沉淀形成。持续搅拌反应6h,停止反应。反应液减压蒸除溶剂后得到化合物2(63.51g,84%)。1H NMR(400MHz,CDCl3)δ12.78(br,1H),12.03(br,1H),8.40~7.43(m,5H),4.57(s,3H)。In an ice-water bath, HCl gas was passed into a mixed solution of acetonitrile (30 g, 0.720 mol), methanol (35 ml, 0.87 mol) and hexane (150 ml) with stirring; during stirring, a white precipitate gradually formed. Continue to stir the reaction for 6h, stop the reaction. The solvent was distilled off from the reaction solution under reduced pressure to obtain compound 2 (63.51 g, 84%). 1H NMR (400MHz, CDCl3) δ12.78 (br, 1H), 12.03 (br, 1H), 8.40-7.43 (m, 5H), 4.57 (s, 3H).
实施例3.乙基5-甲基-4H-1,2,4-三唑-3-乙酸酯3的制备Example 3. Preparation of ethyl 5-methyl-4H-1,2,4-triazole-3-acetate 3
化合物1(13.08g,0.09mol)悬浮于异丙醇(70ml)中,然后滴加Hoenig碱(NEt(i-Pr)2,70ml)和化合物2(12.6g,0.16mol)。反应混合物在室温下搅拌10分钟,然后在油浴中加热回流反应3天。蒸除溶剂,所得残留物用乙酸乙酯稀释后,用盐水洗涤后,用无水硫酸钠干燥。减压蒸除乙酸乙酯,所得残留物用乙酸乙酯/石油醚的混合溶剂进行重结晶,得到目标化合物3(10.87g,71%),为白色固体。1H NMR(400MHz,CDCl3)δ4.24(q,J=7.1Hz,2H),3.82(s,2H),2.41(s,3H),1.29(t,J=7.1Hz,3H)。Compound 1 (13.08g, 0.09mol) was suspended in isopropanol (70ml), then Hoenig base (NEt(i-Pr)2, 70ml) and compound 2 (12.6g, 0.16mol) were added dropwise. The reaction mixture was stirred at room temperature for 10 minutes, then heated to reflux in an oil bath for 3 days. The solvent was evaporated, and the resulting residue was diluted with ethyl acetate, washed with brine, and dried over anhydrous sodium sulfate. Ethyl acetate was distilled off under reduced pressure, and the resulting residue was recrystallized from a mixed solvent of ethyl acetate/petroleum ether to obtain the target compound 3 (10.87 g, 71%) as a white solid. 1H NMR (400MHz, CDCl3) δ 4.24 (q, J = 7.1 Hz, 2H), 3.82 (s, 2H), 2.41 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H).
实施例4.5-甲基-4H-1,2,4-三唑-3-乙酸I的制备The preparation of embodiment 4.5-methyl-4H-1,2,4-triazole-3-acetic acid I
化合物3(4g,23.5mmol)溶于水(30ml)和甲醇(20ml)中,然后分批加入氢氧化钠(1.22g,1.22mol);所得混合物在室温下搅拌过夜。减压蒸除溶剂,所得残留物溶解于乙醚(45ml)中,在0~5℃下搅拌通入氯化氢气体,在搅拌过程中,有白色沉淀形成;过滤并干燥后得到目标化合物I(2.95g,87%);1H NMR(400MHz,DMSO-d6):δ3.98(s,2H),2.57(s,3H);LC-MS>99%(Purity)142(M+H)+。Compound 3 (4g, 23.5mmol) was dissolved in water (30ml) and methanol (20ml), then sodium hydroxide (1.22g, 1.22mol) was added in portions; the resulting mixture was stirred overnight at room temperature. The solvent was evaporated under reduced pressure, and the obtained residue was dissolved in ether (45ml), stirred and passed into hydrogen chloride gas at 0-5°C, during the stirring process, a white precipitate was formed; after filtering and drying, the target compound I (2.95g , 87%); 1H NMR (400MHz, DMSO-d6): δ3.98(s, 2H), 2.57(s, 3H); LC-MS>99% (Purity) 142(M+H)+.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711009139.2A CN107629014A (en) | 2017-10-25 | 2017-10-25 | The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711009139.2A CN107629014A (en) | 2017-10-25 | 2017-10-25 | The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107629014A true CN107629014A (en) | 2018-01-26 |
Family
ID=61106350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711009139.2A Pending CN107629014A (en) | 2017-10-25 | 2017-10-25 | The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107629014A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113387834A (en) * | 2021-06-10 | 2021-09-14 | 苏州工业园区服务外包职业学院 | Continuous synthesis method of 3-oxo-3-hydrazino ethyl propionate |
-
2017
- 2017-10-25 CN CN201711009139.2A patent/CN107629014A/en active Pending
Non-Patent Citations (5)
Title |
---|
DMITRO M. KHOMENKO等: "Synthesis and study of novel 1,2,4-triazolylacetic acid derivatives", 《CHEMISTRY OF HETEROCYCLIC COMPOUNDS》 * |
HATEM A.ABDEL-AZIZ等: "Synthesis and anticancer potential of certain novel 2-oxo-N-(2-oxoindolin-3-ylidene)-2H-chromene-3-carbohydrazodes", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
MARIO DI BRACCIO等: "1,8-Naphthyridines VI. Synthesis and anti-inflammatory activity of 5-(alkylamino)-N,N-diethyl[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides with a new substitution pattern on the triazole ring", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
SCOTT S. WOODARD等: "Combinatorial synthesis of 3,5-dimethylene substituted 1,2,4-triazoles", 《COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING》 * |
YONGXING TANG等: "Nitramino- and Dinitromethyl-Substituted 1,2,4-Triazole Derivatives as High-Performance Energetic Materials", 《CHEM. EUR. J.》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113387834A (en) * | 2021-06-10 | 2021-09-14 | 苏州工业园区服务外包职业学院 | Continuous synthesis method of 3-oxo-3-hydrazino ethyl propionate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101377778B1 (en) | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof | |
JP2020515557A (en) | Synthesis of MCL-1 inhibitor | |
AU2013293974B2 (en) | Method for Producing 4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridin-2-Carbonitrile, and Intermediate thereof | |
JP6078563B2 (en) | Process for preparing phenyl substituted 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid N-methoxy- [1-methyl-2-phenylethyl] amide | |
CN103649055B (en) | For the preparation of the method for pyrazole derivatives | |
JP2740250B2 (en) | Hetera-aliphatic carboxamide derivative, method for producing the same, intermediate of the compound, and pharmaceutical composition containing leukotriene antagonism containing the compound | |
JP2016153411A (en) | Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salt | |
CN107629014A (en) | The synthetic method of the acetic acid of 5 methyl 4H, 1,2,4 triazoles 3 | |
CN107163029A (en) | A kind of improved HSP90 inhibitor Ganetespib preparation method | |
CN110790713A (en) | A regioselective one-step method for the synthesis of 2-hydroxyquinoxalines | |
CN104628647A (en) | Preparation method of 3-methyl-1-(3,4-dimethylphenyl)-2-pyrazoline-5-one | |
WO2019076316A1 (en) | Preparation method for tyrosine kinase inhibitor and intermediate thereof | |
CN102391144A (en) | Synthetic method of (R)-oleoyl propanolamine | |
SG182438A1 (en) | Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt | |
TWI361807B (en) | Process for preparing substituted 4-alkoxycarbonyl-3-aminothiophenes | |
CN101085758A (en) | 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivative, preparation method and application thereof | |
US7256304B2 (en) | Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these | |
JP4855392B2 (en) | Method for preparing 1,5-diphenylpyrazolecarboxylic acid derivative | |
JPH07118238A (en) | Process for producing 1-alkyl-5-pyrazolecarboxylic acid esters | |
CN101591291B (en) | Synthesis method of 2-ethenyl quinoline compound | |
CN118834203A (en) | Preparation method of Rayleigh Lu Geli intermediate | |
JP4616770B2 (en) | Selective amino substituent introduction method | |
JP2022540142A (en) | Method for preparing substituted pyrazole derivatives | |
JP6169721B2 (en) | Method for synthesizing hydrazine that can be used in the treatment of papillomavirus | |
CN101585810B (en) | Preparation method of 5-(4-chlorphenyl)-1-(2, 4-dichlorophenyl) 4- methylpyrazole-3-formic ether |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180126 |
|
RJ01 | Rejection of invention patent application after publication |